You are here

Structural Heart

 

Patients undergoing transcatheter aortic valve replacement (TAVR) had major improvements in health status 30 days and one year after the procedure, according to an observational cohort study.

Parents of children with congenital heart disease would like to see public reporting of survival statistics, surgeon-specific experience and complication rates, according to a recent survey. The preferences were consistent across differences in education level, annual household income and race/ethnicity.

New research from Boston University School of Medicine (BUSM) provides evidence on the links between common mutations in blood cells and atherosclerosis in elderly patients.

After one month, patients with severe aortic stenosis and intermediate surgical risk had improved health status if they underwent transcatheter aortic valve replacement (TAVR) rather than surgical aortic valve replacement (SAVR), according to an analysis of a randomized study. The analysis also found that patients in both groups had similar quality of life outcomes at two years.

David J. Cohen, MD, MSc, and the chief medical officers of three stent companies discuss stents, strategy and the future of healthcare.

 

Recent Headlines

Patients undergoing TAVR show significant health status improvement at 1 year

Patients undergoing transcatheter aortic valve replacement (TAVR) had major improvements in health status 30 days and one year after the procedure, according to an observational cohort study.

Parents of children with congenital heart defects may experience mental health issues

Parents of children with critical congenital heart defects have an elevated risk of trauma, depression and psychological distress, particularly in the weeks and months after their children undergo cardiac surgery, according to a systematic review.

Researchers find link between altitude of living spaces, metabolic syndrome

Living in the mountains could be good for the heart, according to a new study that suggests the higher altitude someone lives in, the less likely they are to develop metabolic syndrome.

Parents of children with congenital heart disease seek survival data, surgeon experience, complication rates

Parents of children with congenital heart disease would like to see public reporting of survival statistics, surgeon-specific experience and complication rates, according to a recent survey. The preferences were consistent across differences in education level, annual household income and race/ethnicity.

Edwards Lifesciences completes $340 million acquisition of Valtech Cardio

Edwards Lifesciences completed its acquisition of Valtech Cardio Ltd. on Jan. 23 for $340 million in stock and cash.

Boston University researchers identify link in blood cell mutations, atherosclerosis

New research from Boston University School of Medicine (BUSM) provides evidence on the links between common mutations in blood cells and atherosclerosis in elderly patients.

Medtronic launches Evolut R 34 mm TAVR system in Europe

Medtronic announced that it had received a CE mark for its Evolut R 34 mm transcatheter aortic valve replacement (TAVR) system. The company also said in the Jan. 17 news release that it had launched the valve in Europe.

CMS approves Watchman study for patients with nonvalvular atrial fibrillation

CMS recently approved a randomized study to assess the Watchman device (Boston Scientific) in patients unsuitable for oral anticoagulation.

AHA statement focuses on managing pregnant women with congenital heart disease

A new scientific statement from the American Heart Association (AHA) provides physicians with guidance on how to treat women with congenital heart disease who become pregnant and manage their risks of miscarriage and other complications.

College football linemen at increased risk of hypertension

Changes in blood pressure and thickening of the heart walls are seen more often in this specific position. 

Pages